XOMA
NASDAQ · Biotechnology
Xoma Royalty Corporation
$42.07
+0.12 (+0.29%)
Open$41.93
Previous Close$41.95
Day High$42.14
Day Low$41.81
52W High$42.81
52W Low$22.29
Volume—
Avg Volume105.3K
Market Cap740.56M
P/E Ratio21.90
EPS$2.00
SectorBiotechnology
Analyst Ratings
Buy
9 analysts
Price Target
-4.9% upside
Current
$42.07
$42.07
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.31M | 33.35M | 45.56M |
| Net Income | 31.20M | -14,563,878 | -2,452,418 |
| Profit Margin | 60.8% | -46.1% | -5.4% |
| EBITDA | 34.99M | -22,420,452 | -2,902,540 |
| Free Cash Flow | — | — | -1,967,070 |
| Rev Growth | +105.3% | -9.3% | +14.7% |
| Debt/Equity | 1.05 | 1.44 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |